Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 37 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
361 20.0 months metastatic breast cancer 4 Chemotherapy
Institute Sainte Catherine France 6/2005
Treatment Details: Patients: This Phase II study involved 49 women with metastatic breast cancer. The median age was 55 and the majority of patients had undergone previous radiotherapy (65%) or chemotherapy (
 
362 19.9 months Metastatic Colorectal Cancer 4 Biologic therapy
Chemotherapy
University Hospital Gasthuisberg Belgium 4/2009
Treatment Details: Patients: The patients in this study were separated into 2 treatment groups (arms). Arm A involved 599 patients, 61.6% of whom were male. Arm B also involved 599, 59.4% of whom were male.
 
363 19.9 months Advanced breast cancer 4 Hormone
Hospital Universitario Arnau de Vilanova Spain 6/2011
Treatment Details: Patients: This study involved postmenopausal women with advanced breast cancer who were divided into 2 separate treatment groups. Group A had 51 patients with a median age of 71.6 years.
 
364 19.8 months GBM 5 Biologic therapy
Chemotherapy
Radiation
University of California, San Francisco United States 7/2014
Treatment Details: Patients: This phase 2 study involved 59 glioblastoma patients with a median age of 54 years. No gender information was provided. Treatment: Patients received radiation therapy, chemo
 
365 19.8 months Advanced Metastatic Breast Cancer 4 Chemotherapy
Peking Union Medical College China 6/2015
Treatment Details: Patients: This phase 3 study involved female advanced metastatic breast cancer patients who were divided into two separate treatment groups. Group A consisted of 104 patients with a median
 
366 19.8 months Metastatic renal cell carcinoma 5 Biologic therapy
Unité Immunothérapie, Institut Gustave Roussy France 9/2009
Treatment Details: Patients: This phase 2 study involved 107 patients with metastatic renal cell carcinoma (kidney cancer). Their median age was 59, ranging from 29 to 80 years of age. These patients had pre
 
367 19.8 months Castration-resistant prostate cancer 4 Chemotherapy
Hormone
University of Siena Italy 2/2011
Treatment Details: Patients: This study involved male patients with advanced castration-resistant prostate cancer that were divided into two separate treatment groups. Group A included 37 patients with a med
 
368 19.8 months Metastatic colorectal cancer 4 Chemotherapy
Glasgow University United Kingdom 4/2008
Treatment Details: Patients: This phase III study involved 2,034 patients with metastatic colorectal cancer. There were 1,207 men and 827 women, and the majority (1,294) were under the age of 65. Most had n
 
369 19.7 months Advanced renal cell carcinoma 3 Biologic therapy
Immunotherapy
Christie Hospital NHS Trust United Kingdom 2/2007
Treatment Details: Patients: This phase II study involved 43 patients with renal cell carcinoma. Of these patients, most (35) were men. Treatment: All patients were treated with a 5T4 oncofoetal antig
 
370 19.7 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Oslo University Hospital Norway 5/2012
Treatment Details: Patients: This study involved previously untreated metastatic colorectal cancer patients who were divided into separate treatment groups. Group A consisted of 185 patients with a median a
 
Page 37 of 187  | Previous Page  | Next Page